ArticleTrials2026

Efficacy of different doses of platelet-rich plasma for moderate carpal tunnel syndrome: study protocol for a prospective, randomized, controlled trial in Guangzhou, China.

Yuxi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.